What we're reading, December 11, 2015: CMS penalized hospitals for patient safety deficiences; MedPAC approved reducing Medicare Advantage plan reimbursement; and Kentuckians favor keeping Medicaid expansion.
More than 750 hospitals were penalized for higher rates of patient safety incidents, according to data from CMS. Kaiser Health News reported that more than half of the 758 hospitals penalized were also fined last year and some well-known institutions, such as Stanford Health Care, Denver Health Medical Center, and 2 hospitals run by the Mayo Clinic Health System, are being punished for the first time. Medicare payments to penalized hospitals will be reduced by 1% over the course of the year.
Meanwhile, Medicare Advantage plan reimbursement will be reduced by at least $200 million. The Medicare Payment Advisory Commission supports Congressional legislation that would allow the HHS secretary to eliminate benchmark caps and the “double bonuses” now available to plans, reported Modern Healthcare.
Medicaid expansion in the state of Kentucky may not be going anywhere if residents have a say. A poll from the Kaiser Family Foundation found that although the state’s new governor, Republican Matt Bevin, opposes the Affordable Care Act and has called for reversing Medicaid expansion, 7 in 10 residents want the program to stay as it is. According to The New York Times, even a majority of Republicans said they would prefer not to scale back Medicaid to cover fewer people.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More